Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: science – Page 130

It reminds of the medieval knight armor.

Power Armor. A powered exoskeleton with a tough outer shell, coupled with twice the mobility of a normal soldier and the strength of an elephant.

For decades, media has emulated what scientists have been struggling to create for millennia. Armor strong enough to both protect the wearer, and strengthen them through mechanical support.

In recent years, researchers have nearly achieved this kind of technology, with body armor reaching durability tougher than steel, and hobbyists making exoskeletons which can lift hundreds of pounds.

Read more

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

regenerage

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.

recovering patient

The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.

Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”

bioquarklogo

About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About RegenerAge SAPI de CV

RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

We spend our lives surrounded by hi-tech materials and chemicals that make our batteries, solar cells and mobile phones work. But developing new technologies requires time-consuming, expensive and even dangerous experiments.

Luckily we now have a secret weapon that allows us to save time, money and risk by avoiding some of these experiments: computers.

Thanks to Moore’s law and a number of developments in physics, chemistry, computer science and mathematics over the past 50 years (leading to Nobel Prizes in Chemistry in 1998 and 2013) we can now carry out many experiments entirely on computers using modelling.

Read more

A new story with lots of transhumanism in it:

Zoltan Istvan is in the running for President of the United States. You may not have heard of him, but if elected, he hopes to put an end to death. All of it. (Yes, seriously).

There are people right now walking around with artificial hearts – something that many people believed would not happen for another decade (or even longer). There are quadriplegics no longer bound to a wheelchair, but walk with exoskeleton technology. There are hundreds of thousands of people with brain implants that help them with various ailments. In short, recent technological breakthroughs like these open up the possibility for humans to enhance themselves and their health—and perhaps to even become immortal (someday).

As you can imagine, such radical developments demand strong, intelligent and science-focused political leadership. That is why Zoltan Istvan, of the Transhumanist Party, says that he is running for U.S. President this year, as the #ScienceCandidate.

Continue reading “The U.S. Presidential Candidate Who Loves Science, Technology, And…Immortality?” | >

Nice paper on QC from the Obama Administration. While reading this paper; I also kept in mind why the US, Europe, Canada, etc. all must accelerate our efforts on QC which is government backed hackers in China, etc. especially since China will have a Quantum Internet and have also accelerated their efforts on QC with their partnership with Australia’s QC efforts which many discoveries on QC has happened.

Read more

Nice.

Elite endurance athletes could be able to keep going for longer thanks to a new drink developed to give soldiers extra energy in battle, a study using former Olympians has found.

Scientists found that cyclists using the drink, which temporarily switches the body’s energy source from glucose to ketones, could travel an extra quarter of a mile than those taking a different energy supplement.

The idea of developing the ketone drink came from the US Army’s research branch, DARPA, who invited scientists to create the most energy efficient food that soldiers could take onto the battlefield.

Continue reading “How science could help cyclists to keep pedalling for longer” | >

A 6-min interview on transhumanism with The Young Turks from the Democratic National Convention in Philadelphia:

TYT’s Jimmy Dore spoke with Zoltan Istvan, the Transhumanist candidate for President of the United States. Istvan touched on the importance of scientific advancement in American politics, and discussed the unique aspects of the Transhumanist Party.

For more, subscribe to YouTube.com/TYTPolitics

Continue reading “The Pro-Science Presidential Candidate” | >

We spend our lives surrounded by high-tech materials and chemicals that make our batteries, solar cells and mobile phones work. But developing new technologies requires time-consuming, expensive and even dangerous experiments.

Luckily we now have a secret weapon that allows us to save time, money and risk by avoiding some of these experiments: computers.

Thanks to Moore’s law and a number of developments in physics, chemistry, computer science and mathematics over the past 50 years (leading to Nobel Prizes in chemistry in 1998 and 2013) we can now carry out many experiments entirely on computers using modeling.

Read more